Related references
Note: Only part of the references are listed.Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors
Boichuk Sergei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Aza-Analogous Benzo[c]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties
Georg Aichinger et al.
MOLECULES (2020)
Dephosphorylation of Plk1 occurs through PP2A-B55/ENSA/Greatwall pathway during mitotic DNA damage recovery
Shin-Young Kim et al.
CELL CYCLE (2019)
Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Wenjie Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M
Qingdi Quentin Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas
Henriett Butz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells
Daiying Zuo et al.
TOXICOLOGY IN VITRO (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Boldine Inhibits Mouse Mammary Carcinoma In Vivo and Human MCF-7 Breast Cancer Cells In Vitro
Pavel Tomsik et al.
PLANTA MEDICA (2016)
Dicentrine Analogue-Induced G2/M Arrest and Apoptosis through Inhibition of Topoisomerase II Activity in Human Cancer Cells
Huei-Fang Lin et al.
PLANTA MEDICA (2015)
Microtubule-binding agents: a dynamic field of cancer therapeutics
Charles Dumontet et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
F. Al-Ejeh et al.
ONCOGENE (2010)
Polo-like kinase 1 reaches beyond mitosis-cytokinesis, DNA damage response, and development
Tohru Takaki et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells
L Dassonneville et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
